KIORA PHARMACEUTICALS INC (KPRX) › Cash & EquivalentsKIORA PHARMACEUTICALS INC (KPRX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2013: $501.2K2014: $167.0K2015: $8.39M2016: $3.64M2017: $7.81M2018: $8.00M2019: $3.78M2020: $1.19M2021: $7.85M2022: $5.96M2023: $2.45M2024: $3.79M2025: $8.70M$8.70M2013Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$8.70M+129.3%2024$3.79M+54.5%2023$2.45M-58.8%2022$5.96M-24.1%2021$7.85M+562.5%2020$1.19M-68.6%2019$3.78M-52.8%2018$8.00M+2.5%2017$7.81M+114.7%2016$3.64M-56.7%2015$8.39M+4926.4%2014$167.0K-66.7%2013$501.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share